Abstract:Objective To investigate the inhibitory effect of CDDP (Cisplatin, cis dichlorodiamine platinum) on telomerase activity in uveal melanoma cells of human eyes and to provide evidence for clinical treatment of uveal melanoma. Methods CDDP treatment with varying concentrations and definite time, and with various CDDP interference time and definite concentration, were applied to the uveal melanoma cells of human eyes cultured in vitro. The changes of telomerase activity in cells were detected by polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA) and polymerase chain reaction- polyscrylamide gel electrophoresis (PCR- PAGE). Results With 72 hours treatment,telomerase activity began to decrease with 0.10 mg/L CDDP and reached the lowest level (0.173±0.007) with 1.00 mg/L CDDP. With a definite concentration ( 10.00 mg/L CDDP), telomerase activity was inhibited after 24 hours, and reached the lowest level (0.276±0.024) after 48 hours. Namely, along with higher level of CDDP and longer time of treatment, telomerase activity was reduced (P＜0.05), and fewer color bands of telomerase activity was visualized on PCR-PAGE. Conclusion CDDP can effectively inhibit the tolemerase activity of uveal melanoma cells of human eyes cultured in vitro in a concentration- and time-dependent manner.

CDDP Inhibition of Telomerase Activity in Uveal Melanoma Cells